Lanzone 1991.
Study characteristics | |||
Patient sampling |
Primary objective: to evaluate CA‐125 in serum and peritoneal fluid of women with various stages of endometriosis and in the control subjects Participants: women undergoing laparoscopy for infertility or pelvic pain during luteal phase of the cycle Selection criteria: exclusion criteria: peritoneal fluid positive for mycoplasma and chlamydia Study design: longitudinal single‐gate, prospective recruitment and collection of samples, consecutive series |
||
Patient characteristics and setting |
Clinical presentation: pelvic pain, infertility or both Age: mean age 30 ± 6.5 years, range 19‐44 years (endometriosis group), 30 ± 6.9 years, range 19‐41 years (controls) Number of participants enrolled: 270 participants Number of participants available for analysis: 119 participants (all in luteal cycle phase) Setting: Department of O&G, Universita Catolica del Sacro Cuore Place of study: Rome, Italy Period of study: January 1987 ‐ December 1988 Language: English |
||
Index tests |
Index test: CA‐125 Details of the index test procedure as stated: serum CA‐125 levels measured with radioimmunoassay (CIS Diagnostici); all samples from the same patient were assayed at the same time Threshold for positive result: CA‐125 > 35.0 U/ml ‐ pre‐specified Examiners: not stated Interobserver variability: the inter‐ and intra‐assay CV were 8% and 15% |
||
Target condition and reference standard(s) |
Target condition: endometriosis Prevalence of target condition in the sample: n = 81/270 (30%): stage I‐II 31, stage III‐IV 50; controls n = 38 Reference standard: laparoscopy N = 270 (100%) Description of positive case definition by reference standard test as reported: visual inspection; staging according to the rAFS classification Examiners: not stated |
||
Flow and timing |
Time interval between index test and reference standard: blood samples were collected immediately before surgery Withdrawals: 151 participants were excluded (reason not explained) |
||
Comparative | |||
Key conclusions by the authors | The measurement of serum CA‐125 does not appear to be useful for the diagnosis and management of endometriosis.Therefore, at present, laparoscopy should be considered the most specific and sensitive method of detecting and following the disease | ||
Conflict of interest | Not reported | ||
Notes | The reported estimates for peritoneal fluid and the estimates following medical treatment for endometriosis are not presented in this review The reported diagnostic estimates per stages of severity of endometriosis are not presented in this review |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Was a 'two‐gate' design avoided? | Yes | ||
Unclear | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Was a cycle phase considered in interpretation of the result of index test? | Yes | ||
Unclear | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
High |